Kavar Capital Partners Group, LLC Gsk PLC Transaction History

Kavar Capital Partners Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$42.05 - $47.77 $2.7 Million - $3.07 Million	-64,238 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$40.23 - $47.74 $48,275 - $57,288	1,200 Added 1.9%	64,238 $2.8 Million
Q4 2021 Jan 27, 2022	BUY	$38.88 - $45.31 $26,632 - $31,037	685 Added 1.1%	63,038 $2.78 Million
Q3 2021 Nov 01, 2021	BUY	$38.79 - $43.16 $103,375 - $115,021	2,665 Added 4.46%	62,353 $2.38 Million
Q2 2021 Aug 02, 2021	SELL	$36.52 - $41.46 $47,476 - $53,898	-1,300 Reduced 2.13%	59,688 $2.38 Million
Q1 2021 May 13, 2021	BUY	$34.27 - $40.01 $10,109 - $11,802	295 Added 0.49%	60,988 $2.18 Million
Q4 2020 Feb 05, 2021	BUY	$34.07 - $39.94 $2.07 Million - $2.42 Million	60,693 New	60,693 $2.23 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Kavar Capital Partners Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Kavar Capital Partners Group, LLC with notifications on news.